Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by THOMAS R. PIEBER
983-P: Effect and Safety of Flexible Dose Adjustment With Oral Semaglutide vs. Sitagliptin in Type 2 Diabetes: PIONEER 7
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
1004-P: Oral Semaglutide vs. Placebo in Patients With Type 2 Diabetes and Moderate Renal Impairment: PIONEER 5
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
54-Or: Oral Semaglutide vs. Empagliflozin Added on to Metformin Monotherapy in Uncontrolled Type 2 Diabetes: PIONEER 2
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cardiovascular Safety of Sitagliptin in Patients With Type 2 Diabetes Mellitus: A Pooled Analysis
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Clinical Potential of Treatment With Semaglutide in Type 2 Diabetes Patients
Drugs in Context
Molecular Medicine
Pharmacology
Effect of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus
Journal of Clinical Medicine Research
Sitagliptin Improves Albuminuria in Patients With Type 2 Diabetes Mellitus
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effect of Sitagliptin on Diabetic Profile of Type 2 Diabetes Mellitus Patients
International Journal of Contemporary Medical Research [IJCMR]
Oral Semaglutide in the Management of Type 2 Diabetes: A Report on the Evidence to Date
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
